Ming Hsieh - Aug 1, 2022 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Paul Kim as Attorney-in-Fact
Stock symbol
FLGT
Transactions as of
Aug 1, 2022
Transactions value $
$0
Form type
4
Date filed
8/3/2022, 06:55 PM
Previous filing
Jun 17, 2022
Next filing
Aug 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Award $0 +30K $0.00 30K Aug 1, 2022 Direct F1
holding FLGT Common Stock 7.9M Aug 1, 2022 By Trust F2
holding FLGT Common Stock 1K Aug 1, 2022 Uniform Transfer to Minors Account F3
holding FLGT Common Stock 1K Aug 1, 2022 Uniform Transfer to Minors Account F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after August 1, 2022, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date.
F2 Securities held by The Ming Hsieh Trust. Mr. Hsieh is the trustee of The Ming Hsieh Trust (the "Trust") and possesses the sole voting and dispositive power with respect to securities held by the Trust.
F3 Shares held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian and possesses the sole voting and dispositive power.
F4 Shares held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian and possesses the sole voting and dispositive power.